The Effects of Light-Targeted Balance Training on Balance, Functional Performance, and Fear of Falling in Individuals With a History of Falls
27. august 2026 oppdatert av: Uskudar University
The Effects of Light-Targeted Balance Training on Balance, Functional Performance, and Fear of Falling in Individuals With a History of Falls: A Randomized Controlled Trial
In recent years, exercise programs based on visual stimuli have been reported to improve balance and motor control . However, studies investigating the effects of light-targeted balance training on balance, functional performance, and fear of falling in individuals with a history of falls are limited.
The aim of this study is to determine the effects of light-targeted balance training on balance, functional performance, and fear of falling in individuals with a history of falls. In addition, the study aims to investigate whether this training method provides additional benefits compared with traditional balance training. The findings of this study are expected to contribute to the development of rehabilitation programs aimed at preventing falls.
Studieoversikt
Status
Rekruttering
Intervensjon / Behandling
Detaljert beskrivelse
Inclusion Criteria
- Having experienced at least one fall within the previous 12 months.
- Being 18 years of age or older.
- Being able to walk independently or with the assistance of a walking aid.
- Being able to understand and follow verbal and visual instructions.
- Providing voluntary consent to participate in the study and signing the informed consent form.
Exclusion Criteria
- Presence of an acute orthopedic injury or an active musculoskeletal condition causing pain.
- Having undergone lower extremity surgery within the previous 6 months.
- Having advanced neurological disorders (e.g., advanced Parkinson's disease, advanced dementia).
- Having severe vestibular dysfunction or significant visual impairment.
- Having a cardiovascular condition that contraindicates exercise.
- Having advanced systemic diseases that significantly impair balance.
Studietype
Intervensjonell
Registrering (Antatt)
50
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: Shirin Khezritomatari
- Telefonnummer: +905342494709
- E-post: shirin.khezry8401@gmail.com
Studiesteder
-
-
Istanbul
-
Istanbul, Istanbul, Tyrkia (Türkiye), 34000
- Rekruttering
- Uskudar University
-
Ta kontakt med:
- Shirin Khezritomatari, Master student
- Telefonnummer: +905342494709
- E-post: Shirin.khezry8401@gmail.com
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Nei
Beskrivelse
Inclusion Criteria:
- History of at least one fall within the past 12 months
- Age 18 years or older
- Ability to walk independently or with an assistive device
- Ability to understand and follow verbal and visual instructions
- Voluntary participation in the study and provision of written informed consent by signing the informed consent form
Exclusion Criteria:
- Acute orthopedic injury or an active musculoskeletal condition causing pain
- History of lower extremity surgery within the past 6 months
- Advanced neurological disorders (e.g., advanced Parkinson's disease, advanced dementia)
- Severe vestibular dysfunction or significant visual impairment
- Medical conditions that contraindicate exercise due to severe cardiovascular disease
- Advanced systemic diseases that severely affect balance
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Experimental Group
Participants in this group will receive light-targeted balance training in addition to the standard program.
|
Exercises aimed at improving coordination, balance, and functional performance using visual and auditory cues.
|
|
Aktiv komparator: Control Group
Participants in this group will receive standard balance exercises.
|
Conventional balance training exercises.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Balance Performance (Berg Balance Scale)
Tidsramme: Baseline and after 8 weeks of intervention
|
Balance performance is assessed using the Berg Balance Scale (BBS).
The scale consists of 14 functional tasks scored from 0 to 4. The total score ranges from 0 to 56, where higher scores indicate better balance and lower fall risk.
|
Baseline and after 8 weeks of intervention
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Functional Mobility (Timed Up and Go Test - TUG)
Tidsramme: Baseline and after 8 weeks of intervention
|
Dynamic balance and mobility are assessed using the Timed Up and Go (TUG) test.
The time (in seconds) taken to stand up from a chair, walk 3 meters, turn around, walk back, and sit down is recorded.
Shorter completion times indicate better mobility.
|
Baseline and after 8 weeks of intervention
|
|
Change in Dynamic Balance (Y-Balance Test)
Tidsramme: Baseline and after 8 weeks of intervention
|
Dynamic postural control is evaluated using the Y-Balance Test (YBT) in anterior, posteromedial, and posterolateral reach directions for both lower extremities.
Reach distance is normalized to limb length ((reach distance / limb length) x 100) and composite scores are calculated.
|
Baseline and after 8 weeks of intervention
|
|
Change in Lower Body Strength (30-Second Chair Stand Test)
Tidsramme: Baseline and after 8 weeks of intervention
|
Lower extremity functional muscle strength is measured using the 30-Second Chair Stand Test.
The total number of full stands completed from a seated position in 30 seconds is recorded.
A higher number of repetitions indicates greater lower body strength.
|
Baseline and after 8 weeks of intervention
|
|
Change in Gait Speed (10-Meter Walk Test - 10MWT)
Tidsramme: Baseline and after 8 weeks of intervention
|
Walking speed is assessed using the 10-Meter Walk Test (10MWT).
Participants walk a 10-meter course at their comfortable and/or fast walking pace, and the time taken (in seconds) to traverse the intermediate 6 meters is recorded to calculate gait speed (m/s).
|
Baseline and after 8 weeks of intervention
|
|
Change in Fear of Falling (Falls Efficacy Scale-International - FES-I)
Tidsramme: Baseline and after 8 weeks of intervention
|
Fear of falling is evaluated using the 16-item Falls Efficacy Scale-International (FES-I).
Each item is scored on a 4-point Likert scale from 1 (not at all concerned) to 4 (very concerned).
Total score ranges from 16 to 64, with higher scores reflecting greater fear of falling.
|
Baseline and after 8 weeks of intervention
|
|
Change in Balance Confidence (Activities-specific Balance Confidence Scale - ABC)
Tidsramme: Baseline and after 8 weeks of intervention
|
Balance confidence is measured using the 16-item Activities-specific Balance Confidence (ABC) Scale.
Participants rate their confidence in performing specific activities without losing balance on a scale from 0% to 100%.
The overall score is the mean percentage across all items.
|
Baseline and after 8 weeks of intervention
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
31. juli 2026
Primær fullføring (Antatt)
30. september 2026
Studiet fullført (Antatt)
30. september 2026
Datoer for studieregistrering
Først innsendt
15. august 2026
Først innsendt som oppfylte QC-kriteriene
15. august 2026
Først lagt ut (Faktiske)
20. august 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
31. august 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
27. august 2026
Sist bekreftet
1. august 2026
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- 61351342/020-2288
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .